Next Article in Journal
Impact of Adjuvant Atezolizumab on Recurrences Avoided and Treatment Cost Savings for Patients with Stage II-IIIA Non-Small Cell Lung Cancer in Canada
Previous Article in Journal
Applying Implementation Science to Identify Primary Care Providers’ Enablers and Barriers to Using Survivorship Care Plans
 
 
Review

Article Versions Notes

Curr. Oncol. 2024, 31(6), 3291-3300; https://doi.org/10.3390/curroncol31060250
Action Date Notes Link
article html file updated 26 June 2025 03:37 CEST Update https://www.mdpi.com/1718-7729/31/6/250/html
article html file updated 6 June 2024 10:12 CEST Original file -
article pdf uploaded. 6 June 2024 10:10 CEST Version of Record https://www.mdpi.com/1718-7729/31/6/250/pdf
article xml uploaded. 6 June 2024 10:10 CEST Update https://www.mdpi.com/1718-7729/31/6/250/xml
article xml file uploaded 6 June 2024 10:10 CEST Original file -
Back to TopTop